Age, 20 years and older |
|
Colonic evaluation (colonoscopy or barium enema) within the previous 5 years or regular followup at gastrointestinal clinic |
|
Chronic constipation confirmed by at least one of the following three criteria: |
|
Meeting Rome III criteria of constipation |
|
Receiving enema, suppository, or digital maneuver at least once a week in the past three months |
|
Laxative use in more than half time of the last three months |
|
|
Exclusion criteria |
|
|
Known cause of colorectal obstruction or structural lesions (e.g., intestinal neoplasm, anal abscess, anal fistula, anal fissure, rectocele, and megacolon) |
|
Inflammatory bowel disease |
|
Irritable bowel syndrome |
|
Hypothyroidism |
|
Spinal cord injury |
|
Muscular dystrophy |
|
Known severe hepatic or renal insufficiency (e.g., liver cirrhosis or receiving hemodialysis) |
|
Unknown cause of gastrointestinal bleeding or acute infection |
|
Exposure to any other investigational drug within 30 days prior to enrollment |
|
History of allergy to the composition of the study medication |
|
New onset or unstable psychiatric disorders |
|
Pregnancy or breastfeeding |
|
History of alcohol or drug abuse |
|
Any condition associated with poor compliance with medical treatment |
|